Related to ‘SEC’

Third-Party Compliance in the Pharmaceutical & Medical Industries

Wednesday, August 24th, 2016
Read More

Applying Internal Controls to the Extended Enterprise

Tuesday, November 6th, 2018
Read More

From FCPA to Reputation Risk: The Importance of Internal Controls

Tuesday, October 2nd, 2018
Read More

The SEC Cybersecurity Penalty and What it Means for TPRM

Thursday, July 29th, 2021
Read More

Unpacking the SEC’s Speech on Environmental, Social, Governance (ESG) Initiatives

Wednesday, July 7th, 2021
Read More

FCPA Third-Party Risk and Compliance for Pharmaceutical Companies

Thursday, May 19th, 2016
Read More

Beyond Dodd-Frank: Reducing Regulatory Risks

Monday, August 29th, 2016
Read More

G2000 Companies Face Increasing Regulatory Burdens, Complexity

Wednesday, August 31st, 2016
Read More

Reducing Mining Regulatory Risks, Achieving Third-Party Compliance

Wednesday, October 19th, 2016
Read More

Pharmaceutical Companies and Third Party Promotions

Tuesday, March 7th, 2017
Read More

Five Key Trends in ABAC Enforcement Demand A Strategic Response

Tuesday, February 19th, 2019
Read More